Featuring: Mark Richardson, MD, PhD
Director of Functional Neurosurgery, Massachusetts General Hospital
Charles A. Pappas Associate Professor of Neurosciences, Harvard Medical School
Visiting Associate Professor of Brain & Cognitive Sciences, Massachusetts Institute of Technology
Join Dr. Mark Richardson to hear his initial experience and insights on the potential impact of the ClearPoint Prism™ Neuro Laser Therapy System, the next generation of laser interstitial thermal therapy. A live Q&A session will follow.
The ClearPoint® Neuro Navigation Platform
ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode insertion, placement of laser catheters, biopsy, and delivery of approved therapeutics in the brain. Additionally, ClearPoint is currently used in approved clinical trials for delivery of biologics, gene and stem cell therapies to the brain. Our platform has FDA clearance, is CE-marked, and is installed in over 65 active clinical sites in the United States, Canada, and Europe.